The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
The subject must be a patient of the University of Pennsylvania
The subject must be able to provide informed consent
The subject must be 18 years of age or older
You may not be if
. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.
Clareo Health | Collection of Circulating Biomarkers in Pancreatic Cancer
